Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?
GRFS, Therapy
17 Sep 2023

Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?

This study investigated the effects of 8 weeks of Galileo Therapy on different disease related scores (PDDS, MSCF) in MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show not only improvements in PDDS and PSAT-3 by up to 18% but also an increase in HSFC (MS Functional Composite: walking distance, hand function, calculation test) in average by 0.36SD…

Continue reading
Galileo Research Facts No. 82: Can Galileo Therapy improve muscle function and cognition in MS patients?
GRFS, Therapy
16 Sep 2023

Galileo Research Facts No. 82: Can Galileo Therapy improve muscle function and cognition in MS patients?

This study investigated the effects of 8 weeks of Galileo Therapy on the disability status of MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show significant improvements in muscle function, cognition and disability status: +0,4 points motor function & cognition, +8% hand motor function, +14% disability status, +19% calculating & memory +26% gait speed…

Continue reading